Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


Integrated Drug Discovery

Product Image
Product Description

Success in drug discovery depends on a deep understanding of the physiological context of a disease and on the knowledge of the properties that make a molecule into a therapeutically and commercially successful drug.

Our medicinal chemists use synthetic chemistry as a tool to solve problems in biology, pharmacology, and medicine. The experience and creativity of our medicinal chemistry team play a key role in advancing your project and ensuring ultimate success.

Selcia Discovery applies a consultative approach to ensure thorough understanding of the project objectives and deliverable. Key to success is a comprehensive grasp on your requirements and then providing high quality compounds to help you move your project forward.

Our approach can be tailored to the specialist needs of academic institutions and small biotechs where we can be the medicinal chemistry resource supporting you with the following key skills

  • Medicinal chemistry expertise
  • Computational chemistry tools
  • Synthetic excellence ensuring speedy execution of synthesis programmes
  • Patent knowledge
  • In-house biology and in vitro ADME
  • Managing outsourced studies
  • Project management

Product Integrated Drug Discovery
Company Selcia Discovery Services
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Selcia Discovery Services
Fyfield Business & Research Park, Fyfield Road, Ongar, Essex CM5 0GS UK

Tel: +44 (0) 1277 367 000
Fax: +44 (0) 1277 367 099
Email: contact@selcia.com



Scientific News
Turning Skin Cells into Heart, Brain Cells
In a major breakthrough, scientists at the Gladstone Institutes transformed skin cells into heart cells and brain cells using a combination of chemicals.
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
Doubling Down on Dengue
HMS researchers have discovered two ways a compound blocks dengue virus.
Reprogramming Scorpion Venom
‘Twist of nature’ neutralizes toxin.
Tailoring a Suit for Tumor-Penetrating Cancer Meds
For more than a decade, biomedical researchers have been looking for better ways to deliver cancer-killing medication directly to tumors in the body.
Resurrecting an Abandoned Drug
Previously discarded drug shows promise in helping human cells in a lab dish fight off two different viruses.
Safer, Cheaper, Greener and More Efficient System for Organic Synthesis
The new medium not only supports organic synthesis it also produces considerably higher yields of product than pure organic solvents.
Fighting Prostate Cancer
Identifying the most promising compounds which can be used as medications for prostate cancer.
Collaboration to Develop Cancer Therapeutics
Major license agreement with Merck, enabled by Blavatnik Biomedical Accelerator, aims to develop therapy for most common form of acute leukemia.
Faster UVA Molecular Analysis Technology
There are people in the world – chemical engineers, astronomers, national defense scientists investigating an explosion – who need to know just what something is made of, down to the molecular level.

SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!